Sheila M. Dreher‐Lesnick

1 ta ish

Center for Biologics Evaluation and Research

1. U.S. Regulatory Considerations for Development of Live Biotherapeutic Products as Drugs

   Sheila M. Dreher‐Lesnick, Scott Stibitz, Paul E. Carlson

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.220033